E-cadherin inhibits nuclear accumulation of Nrf2: Implications for chemoresistance of cancer cells

Journal of Cell Science

Volumn 125, Issue 5, 2012, Pages 1284-1295

  Kim, Won Dong ^a   Kim, Young Woo ^a   Cho, Il Je ^a   Lee, Chang Ho ^b   Kim, Sang Geon ^a  

^a Seoul National University   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

B catenin; E cadherin; Keap1; Nrf2

Indexed keywords

ALANINE; BETA CATENIN; GLUTATHIONE TRANSFERASE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; SERINE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2; UVOMORULIN;

ARTICLE; ATTENUATION; CANCER CELL; CARBOXY TERMINAL SEQUENCE; CHEMOREACTIVITY; COMPLEX FORMATION; CONTROLLED STUDY; GENE INDUCTION; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MUTATION; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSACTIVATION; UBIQUITINATION;

BETA CATENIN; CADHERINS; CELL ADHESION; CELL LINE; CELL LINE, TUMOR; CELL TRANSDIFFERENTIATION; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HEP G2 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASM METASTASIS; NEOPLASMS; NF-E2-RELATED FACTOR 2; PHOSPHORYLATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84861389705     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.095422     Document Type: Article

References (39)

1. Angst, B. D., Marcozzi, C. and Magee, A. I. (2001). The cadherin superfamily: diversity in form and function. J. Cell Sci. 114, 629-641.
2. Arumugam, T., Ramachandran, V., Fournier, K. F., Wang, H., Marquis, L., Abbruzzese, J. L., Gallick, G. E., Logsdon, C. D., McConkey, D. J. and Choi, W. (2009). Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res. 69, 5820-5828.
3. Cho, I. J., Kim, Y. W., Han, C. Y., Kim, E. H., Anderson, R. A., Lee, Y. S., Lee, C. H., Hwang, S. J. and Kim, S. G. (2010). E-cadherin antagonizes transforming growth factor b1 gene induction in hepatic stellate cells by inhibiting RhoAdependent Smad3 phosphorylation. Hepatology 52, 2053-2064.
4. Cho, M. K., Kim, W. D., Ki, S. H., Hwang, J. I., Choi, S., Lee, C. H. and Kim, S. G. (2007). Role of Galpha12 and Galpha13 as novel switches for the activity of Nrf2, a key antioxidative transcription factor. Mol. Cell. Biol. 27, 6195-6208.
5. Churchman, A. T., Anwar, A. A., Li, F. Y., Sato, H., Ishii, T., Mann, G. E. and Siow, R. C. (2009). Transforming growth factor-beta1 elicits Nrf2-mediated antioxidant responses in aortic smooth muscle cells. J. Cell Mol. Med. 13, 2282-2292.
6. Daugherty, R. L. and Gottardi, C. J. (2007). Phospho-regulation of Beta-catenin adhesion and signaling functions. Physiology (Bethesda) 22, 303-309.
7. Drees, F., Pokutta, S., Yamada, S., Nelson, W. J. and Weis, W. I. (2005). Alphacatenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actinfilament assembly. Cell 123, 903-915.
8. Felton, V. M., Borok, Z. and Willis, B. C. (2009). N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition. Am. J. Physiol. Lung Cell Mol. Physiol. 297, L805-L812.
9. Gumbiner, B. M. (2005). Regulation of cadherin-mediated adhesion in morphogenesis. Nat. Rev. Mol. Cell Biol. 6, 622-634.
10. Hayes, J. D. and McMahon, M. (2009). Nrf2 and Keap1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem. Sci. 34, 176-188.
11. Hoogeboom, D. and Burgering, B. M. (2009). Should I stay or should I go: betacatenin decides under stress. Biochim. Biophys. Acta. 1796, 63-74.
12. Huber, M. A., Kraut, N. and Beug, H. (2005). Molecular requirements for epithelialmesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 17, 548-558.
13. Ikeda, H., Nishi, S and Sakai, M. (2004). Transcription factor Nrf2/MafK regulates rat placental glutathione S-transferase gene during hepatocarcinogenesis. Biochem. J. 380, 515-521.
14. Itoh, K., Tong, K. I. and Yamamoto, M. (2004). Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic. Biol. Med. 36, 1208-1213.
15. Itoh, K., Mimura, J. and Yamamoto, M. (2010). Discovery of the negative regulator of Nrf2, Keap1: a historical overview. Antioxid. Redox Signal. 13, 1665-1678.
16. Jain, A. K., Bloom, D. A. and Jaiswal, A. K. (2005). Nuclear import and export signals in control of Nrf2. J. Biol. Chem. 280, 29158-29168.
17. Jeong, W. S., Jun, M. and Kong, A. N. (2006). Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxid. Redox Signal. 8, 99-106.
18. Kang, K. W., Lee, S. J., Park, J. W. and Kim, S. G. (2002). Phosphatidylinositol 3-kinase regulates nuclear translocation of NF-E2-related factor 2 through actin rearrangement in response to oxidative stress. Mol. Pharmacol. 62, 1001-1010.
19. Kang, M. I., Kobayashi, A., Wakabayashi, N., Kim, S. G. and Yamamoto, M. (2004). Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc. Natl. Acad. Sci. USA 101, 2046-2051.
20. Katoh, Y., Itoh, K., Yoshida, E., Miyagishi, M., Fukamizu, A. and Yamamoto, M. (2001). Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription. Genes Cells 6, 857-868.
21. Ki, S. H., Cho, I. J., Choi, D. W. and Kim, S. G. (2005). Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression. Mol. Cell. Biol. 25, 4150-4165.
22. Kim, T. H., Hur, E. G., Kang, S. J., Kim, J. A., Thapa, D., Lee, Y. M., Ku, S. K., Jung, Y. and Kwak, M. K. (2011). NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1a. Cancer Res. 71, 2260-2275.
23. Kim, Y. W., Zhao, R. J., Park, S. J., Lee, J. R., Cho, I. J., Yang, C. H., Kim, S. G. and Kim, S. C. (2008). Anti-inflammatory effects of liquiritigenin as a consequence of the inhibition of NF-kappaB-dependent iNOS and proinflammatory cytokines production. Br. J. Pharmacol. 154, 165-173.
24. Kobayashi, A., Kang, M. I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K. and Yamamoto, M. (2004). Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 24, 7130-7139.
25. Lau, A., Villeneuve, N. F., Sun, Z., Wong, P. K. and Zhang, D. D. (2008). Dual roles of Nrf2 in cancer. Pharmacol. Res. 58, 262-270.
26. Nguyen, T., Sherratt, P. J., Huang, H. C., Yang, C. S. and Pickett, C. B. (2003). Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. J. Biol. Chem. 278, 4536-4541.
27. Niture, S. K., Jain, A. K. and Jaiswal, A. K. (2009). Antioxidant-induced modification of INrf2 cysteine 151 and PKC-delta-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance. J. Cell Sci. 15, 4452-4464.
28. Park, E. Y., Cho, I. J. and Kim, S. G. (2004). Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer. Cancer Res. 64, 3701-3713.
29. Parrish, A. R., Catania, J. M., Orozco, J. and Gandolfi, A. J. (1999). Chemically induced oxidative stress disrupts the E-cadherin/catenin cell adhesion complex. Toxicol. Sci. 51, 80-86.
30. Rao, R. K., Basuroy, S., Rao, V. U., Karnaky, K. J., Jr and Gupta, A. (2002). Tyrosine phosphorylation and dissociation of occludin-ZO-1 and E-cadherin-beta-catenin complexes from the cytoskeleton by oxidative stress. Biochem. J. 368, 471-481.
31. Satoh, H., Moriguchi, T., Taguchi, K., Takai, J., Maher, J. M., Suzuki, T., Winnard, P. T., Jr, Raman, V., Ebina, M., Nukiwa, T. et al. (2010). Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung. Carcinogenesis 31, 1833-1843.
32. Shibata, T., Ohta, T., Tong, K. I., Kokubu, A., Odogawa, R., Tsuta, K., Asamura, H., Yamamoto, M. and Hirohashi, S. (2008). Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc. Natl. Acad. Sci. USA 105, 13568-13573.
33. Shim, G. S., Manandhar, S., Shin, D. H., Kim, T. H. and Kwak, M. K. (2009). Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the Nrf2 pathway. Free Radic. Biol. Med. 47, 1619-1631.
34. Taguchi, K., Motohashi, H. and Yamamoto, M. (2011). Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16, 123-140.
35. Thévenod, F. and Chakraborty, P. K. (2010). The role of Wnt/beta-catenin signaling in renal carcinogenesis: lessons from cadmium toxicity studies. Curr. Mol. Med. 10, 387-404.
36. Wang, X. J., Sun, Z., Villeneuve, N. F., Zhang, S., Zhao, F., Li, Y., Chen, W., Yi, X., Zheng, W., Wondrak, G. T. et al. (2008). Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 29, 1235-1243.
37. Wheelock, M. J. and Johnson, K. R. (2003). Cadherin-mediated cellular signaling. Curr. Opin. Cell Biol. 15, 509-514.
38. Wheelock, M. J., Shintani, Y., Maeda, M., Fukumoto, Y. and Johnson, K. R. (2008). Cadherin switching. J. Cell Sci. 15, 727-735.
39. Zavadil, J. and Böttinger, E. P. (2005). TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24, 5764-5774.